# Comparison of the Anti-Inflammatory Efficacy of Preemptive Dexamethasone and Etoricoxib

> **NCT05142098** · EARLY_PHASE1 · UNKNOWN · sponsor: **Dow University of Health Sciences** · enrollment: 170 (estimated)

## Conditions studied

- Effect of Drug

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Etoricoxib 60 mg

## Key facts

- **NCT ID:** NCT05142098
- **Lead sponsor:** Dow University of Health Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-08-01
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2021-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05142098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05142098, "Comparison of the Anti-Inflammatory Efficacy of Preemptive Dexamethasone and Etoricoxib". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05142098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*